20. PhiC31 Integrase for Modification of Stem Cells

  1. Uma Lakshmipathy,
  2. Jonathan D. Chesnut and
  3. Bhaskar Thyagarajan
  1. Wonil Edward Jung and
  2. Michele P. Calos

Published Online: 17 APR 2009

DOI: 10.1002/9780470454923.ch20

Emerging Technology Platforms for Stem Cells

Emerging Technology Platforms for Stem Cells

How to Cite

Jung, W. E. and Calos, M. P. (2009) PhiC31 Integrase for Modification of Stem Cells, in Emerging Technology Platforms for Stem Cells (eds U. Lakshmipathy, J. D. Chesnut and B. Thyagarajan), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470454923.ch20

Editor Information

  1. Primary and Stem Cell Systems, Invitrogen Corporation, 5781 Faraday Avenue, Carlsbad, CA 92008, USA

Author Information

  1. Department of Genetics, Stanford University School of Medicine, 300 Pasteur Drive, Room M-334 Stanford, CA 94305-5120, USA

Publication History

  1. Published Online: 17 APR 2009
  2. Published Print: 18 MAR 2009

ISBN Information

Print ISBN: 9780470146934

Online ISBN: 9780470454923

SEARCH

Keywords:

  • PHIC31 integrase for stem cell modification;
  • analysis of integration sites used by C31 integrase in different human cell lines;
  • future use of ϕC31 integrase in generation and stem cell modification

Summary

This chapter contains sections titled:

  • Properties Of ΦC31 Integrase in Mammalian Cells

  • Studies Using ΦC31 Integrase in Stem Cells

  • Future Use of ΦC31 Integrase in Generation and Modification of Stem Cells

  • Acknowledgments

  • References